Literature DB >> 4563026

Immune status of patients with multiple sclerosis. Analysis of primary and established immune responses in 24 patients.

L E Davis, E M Hersh, J E Curtis, R E Lynch, D K Ziegler, J W Neumann, T D Chin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4563026     DOI： 10.1212/wnl.22.9.989

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  10 in total

1.  Surface markers on lymphocytes of multiple sclerosis patients.

Authors:  J Nowak; A Wajgt
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

2.  T and B lymphocytes in multiple sclerosis.

Authors:  R P Lisak; A I Levinson; B Zweiman; N I Abdou
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

3.  A 'profile' of immune responsiveness in multiple sclerosis.

Authors:  G R Symington; I R Mackay; S Whittingham; J White; J D Buckley
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

4.  [Lymphocyte transformation in multiple sclerosis. Demonstration of cell sensitivity to basic myelin protein (author's transl)].

Authors:  E Frick; H Stickl; K H Zinn
Journal:  Klin Wochenschr       Date:  1974-03-01

5.  Rheological and fibrinolytic findings in multiple sclerosis.

Authors:  A Brunetti; G L Ricchieri; G M Patrassi; A Girolami; B Tavolato
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-04       Impact factor: 10.154

6.  Biochemical findings in multiple sclerosis. II. A detailed study of the serum IgA, IgG and IgM levels of 772 MS patients compared with 226 neurological controls.

Authors:  P Delmotte; L Demonty
Journal:  J Neurol       Date:  1976-01-14       Impact factor: 4.849

7.  Antimyelin antibody in multiple sclerosis: no change during immunosuppression.

Authors:  L D Wilkerson; R P Lisak; B Zweiman; D H Silberberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-09       Impact factor: 10.154

8.  Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro.

Authors:  S C Knight; E M Lance; J Abbosh; A Munro; J O'Brien
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

9.  Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years.

Authors:  R E Gonsette; L Demonty; P Delmotte
Journal:  J Neurol       Date:  1977-02-17       Impact factor: 4.849

10.  Tests on peripheral blood cells in multiple sclerosis.

Authors:  S McCrea; M Killen; J Thompson; W A Fleming; T A McNeill; J H Millar
Journal:  Ulster Med J       Date:  1979
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.